Viking Therapeutics (VKTX) had the highest return between October 1, 2023 and March 31, 2024 by a mid-cap US stock, returning 645.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Viking Therapeutics (VKTX) | 10/1/2023 - 3/31/2024 | 645.45% |
Sezzle (SEZL) | 10/1/2023 - 3/31/2024 | 539.12% |
Dave (DAVE) | 10/1/2023 - 3/31/2024 | 477.6% |
Trump Media & Technology (DJTWW) | 10/1/2023 - 3/31/2024 | 450.2% |
CleanSpark (CLSK) | 10/1/2023 - 3/31/2024 | 409.06% |
Avidity Biosciences (RNA) | 10/1/2023 - 3/31/2024 | 293.22% |
Trump Media & Technology (DJT) | 10/1/2023 - 3/31/2024 | 282.71% |
Immunitybio (IBRX) | 10/1/2023 - 3/31/2024 | 215.88% |
Apogee Therapeutics, Inc Common Stock (APGE) | 10/1/2023 - 3/31/2024 | 212.56% |
Ocular Therapeutix (OCUL) | 10/1/2023 - 3/31/2024 | 193.55% |
Kymera Therapeutics (KYMR) | 10/1/2023 - 3/31/2024 | 190.25% |
SoundHound AI (SOUN) | 10/1/2023 - 3/31/2024 | 184.54% |
Oscar Health (OSCR) | 10/1/2023 - 3/31/2024 | 170.36% |
Gap (GAP) | 10/1/2023 - 3/31/2024 | 163.99% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 10/1/2023 - 3/31/2024 | 162.2% |
GeneDx (WGS) | 10/1/2023 - 3/31/2024 | 156.46% |
Scholar Rock (SRRK) | 10/1/2023 - 3/31/2024 | 151.91% |
Banco Macro SA B ADR (BMA) | 10/1/2023 - 3/31/2024 | 149.39% |
Cytokinetics (CYTK) | 10/1/2023 - 3/31/2024 | 138.79% |
Impinj (PI) | 10/1/2023 - 3/31/2024 | 132.84% |
Celcuity LLC (CELC) | 10/1/2023 - 3/31/2024 | 132.26% |
CAVA (CAVA) | 10/1/2023 - 3/31/2024 | 130.43% |
Spirit Aerosystems (SPR) | 10/1/2023 - 3/31/2024 | 124.46% |
Abercrombie & Fitch (ANF) | 10/1/2023 - 3/31/2024 | 120.07% |
HCI (HCI) | 10/1/2023 - 3/31/2024 | 117.2% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
